The impact of blood transfusion on morbidity and mortality after cardiac surgery;O impacto da hemotransfusão na morbimortalidade pós-operatória de cirurgias cardíacas

Brazilian Journal of Cardiovascular Surgery

Volumn 26, Issue 2, 2011, Pages 222-229

  Dorneles, Camila de Christo ^a   Bodanese, Luiz Carlos ^b   Guaragna, João Carlos Vieira da Costa ^b   Macagnan, Fabrício Edler ^b   Coelho, Juliano Cé ^b   Borges, Anibal Pires ^b   Goldani, Marco Antonio ^b   Petracco, João Batista ^b  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Blood transfusion; Cardiac surgical procedures; Hospital mortality; Postoperative complications

Indexed keywords

AGED; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HEART MUSCLE REVASCULARIZATION; HEART VALVE REPLACEMENT; HUMAN; LENGTH OF STAY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; BLOOD TRANSFUSION; COHORT STUDIES; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 80052678967     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/S0102-76382011000200012     Document Type: Article

References (30)

1. Ministério da Saúde (Brasil). Secretaria de Atenção à Saúde. Departamento de Atenção Especializada. Guia para o uso de hemocomponentes. Série A. Normas e Manuais Técnicos. Brasília: Ministério da Saúde;2008. 140p.
2. Alghamdi AA, Davis A, Brister S, Corey P, Logan A. Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs. Transfusion. 2006;46(7):1120-9.
3. Ferraris VA, Ferraris SP. Limiting excessive postoperative blood transfusion after cardiac procedures. A review. Tex Heart Inst J. 1995;22(3):216-30.
4. Souza HJB, Moitinho RF. Estratégias para redução do uso de hemoderivados em cirurgia cardiovascular. Rev Bras Cir Cardiovasc. 2008;23(1):53-9.
5. Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24- institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology. 1998;88(2):327-33.
6. Rogers MA, Blumberg N, Saint S, Langa KM, Nallamothu BK. Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med. 2009;7:37.
7. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559-67.
8. Leal-Noval SR, Rincón-Ferrari MD, García-Curiel A, Herruzo- Avilés A, Camacho-Laraña P, Garnacho-Montero J, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest. 2001;119(5):1461-8.
9. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002;74(4):1180-6.
10. Whitlock R, Crowther MA, Ng HJ. Bleeding in cardiac surgery: its prevention and treatment: an evidence-based review. Crit Care Clin. 2005;21(3):589-610.
11. Karkouti K, Cohen MM, McCluskey SA, Sher GD. A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery. Transfusion. 2001;41(10):1193-203.
12. Johnson RG, Thurer RL, Kruskall MS, Sirois C, Gervino EV, Critchlow J, et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Surg. 1992;104(2):307-14.
13. Magovern JA, Sakert T, Benckart DH, Burkholder JA, Liebler GA, Magovern GJ Sr, et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg. 1996;61(1):27-32.
14. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34(6):1608-16.
15. Möhnle P, Snyder-Ramos SA, Miao Y, Kulier A, Böttiger BW, Levin J, et al; Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients. Intensive Care Med. 2011;37(1):97-109.
16. K, O'Farrell R, Yau TM, Beattie WS; Reducing Bleeding in Cardiac Surgery Research Group. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth. 2006;53(8):781-94.
17. Koch C, Li L, Figueroa P, Mihaljevic T, Svensson L, Blackstone EH. Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg. 2009;88(5):1410-8.
18. Magedanz EH, Bodanese LC, Guaragna JC, Albuquerque LC, Martins V, Minossi SD, et al. Risk score elaboration for mediastinitis after coronary artery bypass grafting. Rev Bras Cir Cardiovasc. 2010;25(2):154-9.
19. Friedman ND, Bull AL, Russo PL, Leder K, Reid C, Billah B, et al. An alternative scoring system to predict risk for surgical site infection complicating coronary artery bypass graft surgery. Infect Control Hosp Epidemiol. 2007;28(10):1162-8.
20. Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blackstone EH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg. 2006;82(5):1747-56.
21. van Straten AH, Bekker MW, Soliman Hamad MA, van Zundert AA, Martens EJ, Schönberger JP, et al. Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up. Interact Cardiovasc Thorac Surg. 2010;10(1):37-42.
22. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and costs after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544-52.
23. Ranucci M. Allogeneic blood transfusions and infections after cardiac surgery. Am Heart J. 2007;153(5):e21.
24. McGrath T, Koch CG, Xu M, Li L, Mihaljevic T, Figueroa P, et al. Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes. Ann Thorac Surg. 2008;86(2):543-53.
25. Veenith T, Sharples L, Gerrard C, Valchanov K, Vuylsteke A. Survival and length of stay following blood transfusion in octogenarians following cardiac surgery. Anaesthesia. 2010;65(4):331-6.
26. Greilich PE, Brouse CF, Whitten CW, Chi L, Dimaio JM, Jessen ME. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilonaminocaproic acid and aprotinin. J Thorac Cardiovasc Surg. 2003;126(5):1498-503.
27. Perthel M, El-Ayoubi L, Bendisch A, Laas J, Gerigk M. Clinical advantages of using mini-bypass system in terms of blood product use, postoperative bleeding and air entrainment: an in vivo clinical perspective. Eur J Cardiothorac Surg. 2007;31(6):1070-5.
28. Sellevold OF, Berg TM, Rein KA, Levang OW, Iversen OJ, Bergh K. Heparin-coated circuit during cardiopulmonary bypass. A clinical study using closed circuit, centrifugal pump and reduced heparinization. Acta Anaesthesiol Scand. 1994;38(4):372-9.
29. Yoda M, Nonoyama M, Shimakura T. Autologous blood donation before elective off-pump coronary artery bypass grafting. Surg Today. 2004;34(1):21-3.
30. Souza DD, Braile DM. Avaliação de nova técnica de hemoconcentração e da necessidade de transfusão de hemoderivados em pacientes submetidos à cirurgia cardíaca com circulação extracorpórea. Rev Bras Cir Cardiovasc. 2004;19(3):287-94.